A rational foundation for micheliolide-based combination strategy by targeting redox and metabolic circuit in cancer cells
Authors:
- 12 April 2022
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 200, 115037
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Role of Glutathione in Cancer Progression and ChemoresistanceOxidative Medicine and Cellular Longevity, 2013
- The AMPK signalling pathway coordinates cell growth, autophagy and metabolismNature Cell Biology, 2011
- Unraveling the Biological Roles of Reactive Oxygen SpeciesCell Metabolism, 2011
- Reactive oxygen species, cellular redox systems, and apoptosisFree Radical Biology and Medicine, 2010
- Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?Nature Reviews Drug Discovery, 2009
- Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family membersCancer Cell, 2006
- Glutathione in Cancer Biology and TherapyCritical Reviews in Clinical Laboratory Sciences, 2006
- GLUTATHIONE TRANSFERASESAnnual Review of Pharmacology and Toxicology, 2005
- Molecular events associated with reactive oxygen species and cell cycle progression in mammalian cellsGene, 2004
- Helenanolide type sesquiterpene lactones. Part 5: The role of glutathione addition under physiological conditionsBioorganic & Medicinal Chemistry, 1999